Original Research December 28, 2022

Prevalence and Correlates of Prescription Stimulant Misuse Among US College Students: Results From a National Survey

Sylvia H. M. Wong, EdM; Courtney Stevens, PhD; Cindy H. Liu, PhD; Justin A. Chen, MD, MPH

J Clin Psychiatry 2023;84(1):22m14420

ABSTRACT

Objective: There is a high prevalence of prescription stimulant misuse (PSM) among college students in the United States (US). Preventing and identifying PSM requires an understanding of risk factors and correlates, but large-scale surveys regarding this issue have been lacking. We present the largest multi-institution study to date on the correlates of PSM among US college students.

Methods: We performed a secondary analysis of the 2017 American College Health Association–National College Health Assessment (ACHA-NCHA), an annual national survey on the demographics, health, and academic experiences of US college students. Logistic regression models examined associations between past-year PSM in 40,645 undergraduate college students and hypothesized risk factors.

Results: PSM was reported in 8% of college students. PSM was associated with past-year diagnosis or treatment of depression (adjusted odds ratio [AOR] = 1.16; 99% CI, 1.01–1.33), anorexia (AOR = 1.44; 99% CI, 1.02–2.03), attention-deficit/hyperactivity disorder (AOR = 1.66; 99% CI, 1.41–1.95), and substance use disorder/other addiction (AOR = 1.79; 99% CI, 1.30–2.46). The odds of PSM were 5.5 times higher for students who endorsed past-month use of “Legal drugs” and 8 times higher for students who endorsed past-month use of “Illegal drugs” than for those who did not. Other factors associated with PSM included academic difficulty, daytime sleepiness, fraternity or sorority involvement, White race, and cis-male gender.

Conclusions: This study identifies many potential risk factors for PSM among US undergraduate college students. Targeted outreach, prevention, and clinical management are discussed. As the COVID-19 pandemic has exacerbated psychiatric distress, sleep difficulties, substance use, and attentional challenges among college students, this study may serve as a baseline for future studies examining the impact of COVID-19 on PSM among college students.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Drugs of Abuse: A DEA Resource Guide. US Department of Justice. DEA website. https://www.dea.gov/sites/default/files/drug_of_abuse.pdf. 2017. Accessed January 28, 2022.
  2. Benson K, Flory K, Humphreys KL, et al. Misuse of stimulant medication among college students: a comprehensive review and meta-analysis. Clin Child Fam Psychol Rev. 2015;18(1):50–76. PubMed CrossRef
  3. DuPont RL, Coleman JJ, Bucher RH, et al. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict. 2008;17(3):167–171. PubMed CrossRef
  4. Teter CJ, McCabe SE, LaGrange K, et al. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26(10):1501–1510. PubMed CrossRef
  5. Carroll BC, McLaughlin TJ, Blake DR. Patterns and knowledge of nonmedical use of stimulants among college students. Arch Pediatr Adolesc Med. 2006;160(5):481–485. PubMed CrossRef
  6. Norman L, Ford J. Undergraduate prescription stimulant misuse: the impact of academic strain. Subst Use Misuse. 2018;53(9):1482–1491. PubMed CrossRef
  7. Blevins CE, Stephens R, Abrantes AM. Motives for prescription stimulant misuse in a college sample: characteristics of users, perception of risk, and consequences of use. Subst Use Misuse. 2017;52(5):555–561. PubMed CrossRef
  8. Goodhines PA, Taylor LE, Zaso MJ, et al. Prescription stimulant misuse and risk correlates among racially-diverse urban adolescents. Subst Use Misuse. 2020;55(14):2258–2267. PubMed CrossRef
  9. Spillane NS, Weyandt L, Oster D, et al. Social contextual risk factors for stimulant use among adolescent American Indians. Drug Alcohol Depend. 2017;179:167–173. PubMed CrossRef
  10. Worley J, Johnson M, Karnik N. Psychiatric prescribers’ experiences with doctor shoppers. J Am Psychiatr Nurses Assoc. 2015;21(5):309–318. PubMed CrossRef
  11. Garnier LM, Arria AM, Caldeira KM, et al. Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry. 2010;71(3):262–269. PubMed CrossRef
  12. Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012;2(5):661–677. PubMed CrossRef
  13. Rabiner DL, Anastopoulos AD, Costello EJ, et al. Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems? J Atten Disord. 2009;13(3):259–270. PubMed CrossRef
  14. Bavarian N, Flay BR, Ketcham PL, et al. The illicit use of prescription stimulants on college campuses: a theory-guided systematic review. Health Educ Behav. 2015;42(6):719–729. PubMed CrossRef
  15. Arria AM, Caldeira KM, O’Grady KE, et al. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy. 2008;28(2):156–169. PubMed CrossRef
  16. Janusis GM, Weyandt LL. An exploratory study of substance use and misuse among college students with and without ADHD and other disabilities. J Atten Disord. 2010;14(3):205–215. PubMed CrossRef
  17. Gallucci AR, Martin RJ. Misuse of prescription stimulant medication in a sample of college students: examining differences between varsity athletes and non-athletes. Addict Behav. 2015;51:44–50. PubMed CrossRef
  18. McCabe SE, Knight JR, Teter CJ, et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;100(1):96–106. PubMed CrossRef
  19. Dussault CL, Weyandt LL. An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations. J Atten Disord. 2013;17(2):87–97. PubMed CrossRef
  20. Ford JA, Schroeder RD. Academic strain and non-medical use of prescription stimulants among college students. Deviant Behav. 2009;30(1):26–53. CrossRef
  21. Benson K, Flory K. Symptoms of depression and ADHD in relation to stimulant medication misuse among college students. Subst Use Misuse. 2017;52(14):1937–1945. PubMed CrossRef
  22. Gibbs EL, Kass AE, Eichen DM, et al. Attention-deficit/hyperactivity disorder-specific stimulant misuse, mood, anxiety, and stress in college-age women at high risk for or with eating disorders. J Am Coll Health. 2016;64(4):300–308. PubMed CrossRef
  23. Lookatch SJ, Dunne EM, Katz EC. Predictors of nonmedical use of prescription stimulants. J Psychoactive Drugs. 2012;44(1):86–91. PubMed CrossRef
  24. Advokat CD, Guidry D, Martino L. Licit and illicit use of medications for attention-deficit hyperactivity disorder in undergraduate college students. J Am Coll Health. 2008;56(6):601–606. PubMed CrossRef
  25. Arria AM, Wilcox HC, Caldeira KM, et al. Dispelling the myth of “smart drugs”: cannabis and alcohol use problems predict nonmedical use of prescription stimulants for studying. Addict Behav. 2013;38(3):1643–1650. PubMed CrossRef
  26. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction. 2007;102(5):740–751. PubMed CrossRef
  27. Garnier-Dykstra LM, Caldeira KM, Vincent KB, et al. Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health. 2012;60(3):226–234. PubMed CrossRef
  28. Kaloyanides KB, McCabe SE, Cranford JA, et al. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy. 2007;27(5):666–674. PubMed CrossRef
  29. Hartung CM, Canu WH, Cleveland CS, et al. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers. Psychol Addict Behav. 2013;27(3):832–840. PubMed CrossRef
  30. Clegg-Kraynok MM, McBean AL, Montgomery-Downs HE. Sleep quality and characteristics of college students who use prescription psychostimulants nonmedically. Sleep Med. 2011;12(6):598–602. PubMed CrossRef
  31. Emanuel RM, Frellsen SL, Kashima KJ, et al. Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students. J Gen Intern Med. 2013;28(8):1028–1034. PubMed CrossRef
  32. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs. 2006;38(1):43–56. PubMed CrossRef
  33. Hall KM, Irwin MM, Bowman KA, et al. Illicit use of prescribed stimulant medication among college students. J Am Coll Health. 2005;53(4):167–174. PubMed CrossRef
  34. Teter CJ, McCabe SE, Boyd CJ, et al. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy. 2003;23(5):609–617. PubMed CrossRef
  35. Kroutil LA, Van Brunt DL, Herman-Stahl MA, et al. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006;84(2):135–143. PubMed CrossRef
  36. Low KG, Gendaszek AE. Illicit use of psychostimulants among college students: a preliminary study. Psychol Health Med. 2002;7(3):283–287. CrossRef
  37. Broman CL, Miller PK, Jackson E. Race-ethnicity and prescription drug misuse: does self-esteem matter? J Child Adolesc Behav. 2015;3(5):239. PubMed CrossRef
  38. Spring 2017 American Health Association National College Health Assessment (ACHA-NCHA IIB) Reference Group [Data File]. American College Health Association. ACHA website. https://acha.org/ncha. 2017. Accessed January 28, 2022.
  39. Chen JA, Stevens C, Wong SHM, et al. Psychiatric symptoms and diagnoses among US college students: a comparison by race and ethnicity. Psychiatr Serv. 2019;70(6):442–449. PubMed CrossRef
  40. Liu CH, Stevens C, Wong SHM, et al. The prevalence and predictors of mental health diagnoses and suicide among US college students: Implications for addressing disparities in service use. Depress Anxiety. 2019;36(1):8–17. PubMed CrossRef
  41. Brittain DR, Dinger MK. An examination of health inequities among college students by sexual orientation identity and sex. J Public Health Res. 2015;4(1):jphr.2015.414. PubMed CrossRef
  42. Gonsalvez I, Li JJ, Stevens C, et al. Preexisting depression and daytime sleepiness in women and men. Behav Sleep Med. 2022 Jul-Aug;20(4):380–392. PubMed
  43. WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–1194. PubMed CrossRef
  44. Humphreys KL, Eng T, Lee SS. Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry. 2013;70(7):740–749. PubMed CrossRef
  45. Vetter JA. Parent-child interaction therapy for autism spectrum and attention deficit/hyperactivity disorders: a review of the literature. Child Fam Behav Ther. 2018;40(3):204–232. CrossRef
  46. Antshel KM, Hargrave TM, Simonescu M, et al. Advances in understanding and treating ADHD. BMC Med. 2011;9:72. PubMed CrossRef
  47. Stewart TD, Reed MB. Lifetime nonmedical use of prescription medications and socioeconomic status among young adults in the United States. Am J Drug Alcohol Abuse. 2015;41(5):458–464. PubMed CrossRef
  48. Caraballo C, Massey D, Mahajan S, et al. Racial and ethnic disparities in access to health care among adults in the United States: a 20-Year national health interview survey analysis, 1999–2018 [preprint November 4, 2020]. medRxiv. doi:10.1101/2020.10.30.20223420.
  49. Riley WJ. Health disparities: gaps in access, quality and affordability of medical care. Trans Am Clin Climatol Assoc. 2012;123:167–172, discussion 172–174. PubMed
  50. Ahmed S, Virani S. Stimulant overprescribing, abuse, and diversion. Am J Psychiatry. 2017;12(9):11–12. CrossRef
  51. Generalizability, Reliability, and Validity Analysis. ACHA website. https://www.acha.org/NCHA/NCHA/About/Generalizability__Reliability__and_Validity_Analysis_NCHA_I.aspx. 2013. Accessed January 28, 2022.
  52. Liu CH, Zhang E, Wong GTF, et al. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for US young adult mental health. Psychiatry Res. 2020;290:113172. PubMed CrossRef
  53. Hyun S, Hahm HC, Wong GTF, et al. Psychological correlates of poor sleep quality among US young adults during the COVID-19 pandemic. Sleep Med. 2021;78:51–56. PubMed CrossRef
  54. Schepis TS, De Nadai AS, Bravo AJ, et al; Stimulant Norms and Prevalence (SNAP) Study Team. Alcohol use, cannabis use, and psychopathology symptoms among college students before and after COVID-19. J Psychiatr Res. 2021;142:73–79. PubMed CrossRef
  55. Oddo LE, Garner AM, Novick D, et al. Remote delivery of psychosocial intervention for college students with ADHD during COVID-19: clinical strategies, practice recommendations, and future considerations. Evid Based Pract Child Adolesc Ment Health. 2020;6(1):99–115. CrossRef